A Phase I study to evaluate the safety and antitumor activity of durvalumab (MEDI4736) in combination with tremelimumab in patients with advanced solid tumors. Issue 2 (December 2015)

Record Type:: Journal Article
Title:: A Phase I study to evaluate the safety and antitumor activity of durvalumab (MEDI4736) in combination with tremelimumab in patients with advanced solid tumors. Issue 2 (December 2015)
Main Title:: A Phase I study to evaluate the safety and antitumor activity of durvalumab (MEDI4736) in combination with tremelimumab in patients with advanced solid tumors
Authors:: Papadopoulos, Kyriakos
Tsai, Frank
Hamid, Omid
Xiao, Feng
Steele, Keith
Rebelatto, Marlon
Robbins, Paul
Karakunnel, Joyson
Lai, Dominic
Mahipal, Amit
Abstract:
Is Part Of:: Journal for immunotherapy of cancer. Volume 3:Issue 2(2015)
Journal:: Journal for immunotherapy of cancer
Issue:: Volume 3:Issue 2(2015)
Issue Display:: Volume 3, Issue 2 (2015)
Year:: 2015
Volume:: 3
Issue:: 2
Issue Sort Value:: 2015-0003-0002-0000
Page Start:: 1
Page End:: 2
Publication Date:: 2015-12
Subjects:: Cancer -- Immunotherapy -- Periodicals
Cancer -- Immunological aspects -- Periodicals
Tumors -- Immunological aspects -- Periodicals
Immunotherapy -- Periodicals
616.99406105
Journal URLs:: http://www.immunotherapyofcancer.org ↗
https://jitc.bmj.com/ ↗
http://link.springer.com/ ↗
DOI:: 10.1186/2051-1426-3-S2-P165 ↗
Languages:: English
ISSNs:: 2051-1426
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:: 10242.xml